P62 inhibits IL-1β release during Salmonella Typhimurium infection of macrophages
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1495567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Nina Judith Hos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germ…. Hauptthemen laut MEDLINE: Macrophages, Interleukin-1beta, Salmonella typhimurium, Sequestosome-1 Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Macrophages are critical for the innate immune defense against the facultative intracellular Gram-negative bacterium Salmo\nella enterica serovar Typhimurium. Following phagocytosis by macrophages, S . Typhimurium activates cytoplasmic NLRC3 and NLRP4 inflammasomes, which share the adaptor ASC, resulting in the secretion of the pro-inflammatory cytokine IL-1β. To prevent excessive inflammation and tissue damage, inflammatory signaling pathways are tightly controlled. Recently, autophagy has been suggested to limit inflammation by targeting activated inflammasomes for autophagic degradation. However, the importance of the autophagic adaptor Sequestome-1 (hereafter, p62) for regulating inflammasome activation remains poorly understood. We report here that p62 restricts inflammasome availability and subsequent IL-1β secretion in macrophages infected with S . Typhimurium by targeting the inflammasome adaptor ASC for autophagic degradation. Importantly, loss of p62 resulted in impaired autophagy and increased IL-1β secretion, as well as IL-10 and IFN-β release. In summary, our results demonstrate a novel role for p62 in inducing autophagy and balancing major pro- and anti-inflammatory signaling pathways to prevent excessive inflammation during S . Typhimurium infection of macrophages.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
- German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
- Department I of Internal Medicine, Division of Infectious Diseases, University of Cologne, Cologne, Germany.
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
- Department B of Internal Medicine, University of Münster, University Hospital of Münster, Münster, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Hos, N. J., Fischer, J., Murthy, A. M. V., Hejazi, Z., Krönke, M., Hos, D., & Robinson, N. (2025). P62 inhibits IL-1β release during Salmonella Typhimurium infection of macrophages. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1495567
Vancouver
Hos NJ, Fischer J, Murthy AMV, Hejazi Z, Krönke M, Hos D, et al. P62 inhibits IL-1β release during Salmonella Typhimurium infection of macrophages. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1495567
BibTeX
@article{Hos2025,
author = {Hos, Nina Judith and Fischer, Julia and Murthy, Ambika M V and Hejazi, Zahra and Krönke, Martin and Hos, Deniz and Robinson, Nirmal},
title = {P62 inhibits IL-1β release during Salmonella Typhimurium infection of macrophages},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1495567}
}
EUVIMED